CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
News|Articles|February 2, 2009
Formulary Digital Edition February 2009
Review of ARV agents for the treatment of HIV infection; Focus on dronedarone; Drug Watch: Agents in late-stage development for the treatment of HIV and AIDS
Advertisement
Advertisement
Related to this article
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Closing the outpatient monitoring gap in cancer
2
New lean MASH mouse model could guide more targeted liver disease treatment in humans
3
Final GLOBE drug model projects much smaller savings while 2027 Part D premiums split
4
A conversation with Jordan Herring, Ph.D., and Carlos E. Rodriguez-Diaz, Ph.D., MPHE, MCHES, about the relationship between HIV incidence in Hispanic communities and immigration policy
5